Category Access to Knowledge/ Education

Year Ahead: Biotech, IP Promise to Create Controversy From Farms To Big Pharma In 2014

The intersection of biotechnology and intellectual property continues to be a hot topic across the globe. From the patenting of certain plant varieties to human genes, to biodiversity and food security, to genetic resources, countries from developing to developed are attempting to navigate often blurred lines in terms of what can and cannot be patented, what should - and shouldn’t - be patented, and protecting innovators from farmers to plant breeders to drug manufacturers.

US Calls On Brazil Internet Meeting To Stick To Principles

The United States, home to the organisation that oversees technical aspects of the internet domain name system, has advice for an upcoming meeting in Brazil aimed at revisiting the global internet governance: consider principles developed in past meetings, and don't retread old sore spots. In other words, don't disrupt the status quo.

Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India

Mike Palmedo at Infojustice.org writes: "The U.S. International Trade Commission (ITC) is currently investigating “Indian industrial policies that discriminate against U.S. imports… and the effect those barriers have on the U.S. economy and U.S. jobs.” The investigation was requested by Sen. Hatch, Sen. Baucus, Rep. Camp, and Rep. Levin, and the final report is due to be released in November. Last week it held a series of hearings, where it heard from U.S. business, Indian business, and civil society representatives."

Interview With Nazeem Mohamed, CEO Of Kampala Pharmaceutical Industries

Nazeem Mohamed is chief executive officer of Kampala Pharmaceutical Industries (KPI), a Ugandan generic manufacturer. Local manufacture of medicines is described by many, including the World Health Organization, as one of the tools that will increase access to medicines. Mohamed is former vice-president of strategic product development at Novo Nordisk, based in Belgium. He also worked for several leading multinational companies such as Pfizer and GlaxoSmithKline before his appointment as CEO of KPI.

With Intellectual Property Watch, Mohamed discussed KPI, the challenges of local drug production, the burden of non-communicable diseases, the issue of substandard medicines, rules engineered in the West which can hinder affordability and access in a least-developed country, unfair competition, and unmet skills building needs.

TTIP: No Lowering Of Standards, Officials Say; New Trade Consultation Body Scrutinised

After three rounds of negotiations for the Transatlantic Trade and Investment Partnership (TTIP), European Union Trade Commissioner Karel de Gucht this week welcomed the progress so far. But negotiators have to “step up a gear,” de Gucht said after a two-day stocktaking meeting with the United States Trade Representative Michael Froman in Washington, DC on 18 February. Meanwhile, USTR announced new steps to raise public participation in trade negotiations.

Infojustice.org: Australia Commits To Overhaul Of Copyright Act

From infojustice.org: [Australian Digital Alliance] It has been a big week for Australian Copyright. On Thursday the Attorney-General, the Hon George Brandis QC, tabled the long-anticipated final report from the Australian Law Reform Commission’s (ALRC) Copyright and the Digital Economy inquiry. This inquiry was charged with determining if copyright exceptions and limitations were working in the digital age. The conclusion was that reform was needed.

Paper Makes Recommendations For Exhaustion Of IP Rights

A recent paper issued by the International Centre for Trade and Sustainable Development (ICTSD) compares existing exhaustion policies and makes recommendations for countries in the process of adopting their own regimes in this area. These have the potential to contribute to economic and social development, innovation and the protection of user rights globally, it said.